Quotient Limited (QTNT) to Post Q3 2018 Earnings of ($0.55) Per Share, Jefferies Group Forecasts
Quotient Limited (NASDAQ:QTNT) – Stock analysts at Jefferies Group upped their Q3 2018 earnings per share (EPS) estimates for Quotient Limited in a report issued on Wednesday. Jefferies Group analyst B. Couillard now expects that the company will earn ($0.55) per share for the quarter, up from their previous forecast of ($0.63). Jefferies Group currently has a “Buy” rating and a $13.00 target price on the stock. Jefferies Group also issued estimates for Quotient Limited’s Q4 2018 earnings at ($0.46) EPS, FY2018 earnings at ($2.12) EPS, Q1 2019 earnings at ($0.40) EPS, Q2 2019 earnings at ($0.14) EPS, Q3 2019 earnings at ($0.31) EPS, Q4 2019 earnings at ($0.29) EPS, FY2019 earnings at ($1.12) EPS and FY2020 earnings at ($0.23) EPS.
A number of other analysts have also recently weighed in on the company. Zacks Investment Research cut Quotient Limited from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 26th. ValuEngine lowered Quotient Limited from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st. Finally, BTIG Research reaffirmed a “buy” rating and set a $12.00 price target on shares of Quotient Limited in a research note on Thursday, August 31st.
COPYRIGHT VIOLATION NOTICE: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2017/11/07/quotient-limited-qtnt-to-post-q3-2018-earnings-of-0-55-per-share-jefferies-group-forecasts.html.
Shares of Quotient Limited (NASDAQ QTNT) traded down $0.11 during trading on Monday, hitting $5.02. The stock had a trading volume of 256,907 shares, compared to its average volume of 403,993. The company has a debt-to-equity ratio of -5.17, a quick ratio of 0.86 and a current ratio of 1.36. Quotient Limited has a fifty-two week low of $3.22 and a fifty-two week high of $7.74.
Quotient Limited (NASDAQ:QTNT) last announced its quarterly earnings data on Monday, August 7th. The company reported ($0.55) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.55). Quotient Limited had a negative return on equity of 13,050.41% and a negative net margin of 404.29%. The firm had revenue of $6.83 million for the quarter, compared to analysts’ expectations of $5.70 million.
In other news, insider D J. Paul E. Cowan sold 100,000 shares of the stock in a transaction on Monday, September 18th. The stock was sold at an average price of $4.41, for a total value of $441,000.00. Following the completion of the sale, the insider now owns 26,666 shares in the company, valued at $117,597.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider D J. Paul E. Cowan sold 30,197 shares of the stock in a transaction on Monday, October 16th. The shares were sold at an average price of $4.92, for a total value of $148,569.24. Following the completion of the sale, the insider now owns 26,666 shares of the company’s stock, valued at approximately $131,196.72. The disclosure for this sale can be found here. Over the last three months, insiders have sold 375,197 shares of company stock valued at $1,639,728. Corporate insiders own 29.00% of the company’s stock.
Several large investors have recently made changes to their positions in QTNT. Schwab Charles Investment Management Inc. purchased a new stake in shares of Quotient Limited during the second quarter worth $341,000. Rhumbline Advisers purchased a new stake in shares of Quotient Limited during the second quarter worth $201,000. Bank of New York Mellon Corp purchased a new stake in shares of Quotient Limited during the second quarter worth $451,000. Birchview Capital LP raised its holdings in shares of Quotient Limited by 36.9% during the second quarter. Birchview Capital LP now owns 79,700 shares of the company’s stock worth $587,000 after acquiring an additional 21,500 shares in the last quarter. Finally, FNY Partners Fund LP raised its holdings in shares of Quotient Limited by 41.8% during the second quarter. FNY Partners Fund LP now owns 129,200 shares of the company’s stock worth $950,000 after acquiring an additional 38,072 shares in the last quarter. Institutional investors and hedge funds own 47.70% of the company’s stock.
About Quotient Limited
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.
Receive News & Stock Ratings for Quotient Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient Limited and related stocks with our FREE daily email newsletter.